XML 46 R35.htm IDEA: XBRL DOCUMENT v3.25.1
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Compensation Expense
Total share-based compensation expense was as follows:
Three Months Ended
March 31,
20252024
(In thousands)
Stock option expense$3,263 $3,509 
Restricted stock expense5,055 4,797 
Performance restricted stock unit expense1,146 635 
Total pre-tax expense$9,464 $8,941 
Schedule of Weighted Average Assumptions Used for Estimating Fair Values of Stock Options Granted The following weighted average assumptions were used in the Black-Scholes-Merton model to estimate the fair values of stock options granted during the periods indicated:
Three Months Ended
March 31, 2025
Year Ended December 31, 2024
Expected volatility22.7 %28.2 %
Expected term (years)5.05.0
Risk-free interest rate4.07 %4.31 %
Expected dividend yield0.70 %0.62 %
Black-Scholes-Merton fair value per stock option granted$46.21 $56.42 
Schedule of Stock Option Activity and Related Information
The following is a summary of the Company’s stock option activity and related information:
SharesWeighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life 
Aggregate
Intrinsic
Value
(In thousands)(Years)(In millions)
Outstanding at December 31, 20242,140 $114.33 
Granted267 176.08 
Exercised(56)99.48 
Forfeited(11)150.68 
Outstanding at March 31, 20252,340 $121.57 6.6$121.5 
Exercisable at March 31, 20251,805 $107.58 5.8$117.2 
Schedule of Nonvested Restricted Stock Activity and Related Information
The following is a summary of the Company’s non-vested restricted stock activity and related information:
SharesWeighted
Average
 Grant Date
Fair Value
(In thousands)
Non-vested restricted stock outstanding at December 31, 2024277 $159.71 
Granted159 176.25 
Vested(131)150.52 
Forfeited(6)161.10 
Non-vested restricted stock outstanding at March 31, 2025299 $172.51 
The following is a summary of the Company’s non-vested performance restricted stock activity and related information:
SharesWeighted
Average
 Grant Date
Fair Value
(In thousands)
Non-vested performance restricted stock outstanding at December 31, 2024235 $150.92 
Granted93 176.08 
Performance assumption change 1
8 134.69 
Vested(92)134.69 
Forfeited(1)153.38 
Non-vested performance restricted stock outstanding at March 31, 2025243 $166.12 
_________________________________________
1 Reflects the number of PRSUs above target levels based on performance metrics.